key: cord-0907099-qsh927du authors: Dennison, David; Khabori, Murtadha Al; Mamari, Sahimah Al; Aurelio, Allan; Hinai, Houda Al; Maamari, Khuloud Al; AlShekaili, Jalila; Khadouri, Ghalib Al title: Circulating activated neutrophils in COVID-19: an independent predictor for mechanical ventilation and death date: 2021-03-26 journal: Int J Infect Dis DOI: 10.1016/j.ijid.2021.03.066 sha: cd5ecbe667568d3718ed82be3a2bb20aa990a7a6 doc_id: 907099 cord_uid: qsh927du Objectives Critical illness in COVID-19 is attributed to an exaggerated host immune response. Since neutrophils are the major component of innate immunity, we hypothesize that the quantum of activated neutrophils in the blood may predict adverse outcome. Design In a retrospective study of 300 Omani adult patients with confirmed COVID-19, we analyzed the impact of neutrophil activation (NEUT-RI), interleukin-6 (IL-6) and the established clinical risk factors of age, diabetes, obesity and hypertension on the clinical outcome. Results Significant predictors of the need for mechanical ventilation were NEUT-RI (OR = 1.22, p < 0.001), diabetes (OR = 2.56, p = 0.00846) and obesity (OR 6.55, p < 0.001). For death, the significant predictors were NEUT-RI (OR = 1.14, p = 0.00432), diabetes (OR = 4.11, p = 0.00185) and age (OR = 1.04, p = 0.00896). The optimal cut-off value for NEUT-RI to predict mechanical ventilation and death was 52 FI (sensitivity 44%, specificity 88%, AUC 0.67 and 44%, 86%, AUC 0.64 respectively). Conclusion This finding supports an aberrant neutrophil response in COVID-19, likely due to uncontained viral replication, tissue hypoxia and exacerbated inflammation, introduces a novel biomarker for rapid monitoring, and opens new avenues for therapeutic strategies. 6 hypercytokinemia, can then lead to generalized thrombogenesis and multi-organ failure (Marini and Gattinoni, 2020). Neutrophils are essential for their function in innate immunity as well as to play an important role in inflammation and the repair of hypoxia-induced tissue damage Neutrophils need to be activated into functional effector cells to fulfill their role in innate immunity and tissue repair (Mayadas et al., 2014) . It is believed that this J o u r n a l P r e -p r o o f process of neutrophil activation begins shortly after recruitment as they roll along the endothelial walls of post capillary venules and sample inflammatory signals (Ley, 2002) . In the setting of severe COVID-19 where the extent of tissue neutrophil activity is thought to be extremely high, it is likely that activated neutrophils are constantly circulating in the peripheral blood. Their detection and quantification could assume importance in COVID-19 to define correlations in disease outcome, improve our understanding of the pathophysiology and perhaps monitor future targeted therapy. A rapid technique to detect activated neutrophils in the peripheral blood attracted our attention using the Sysmex TM XN-9100 automated hematology analyzer. The Sysmex TM XN-series analyzers (Sysmex Corp., Kobe, Japan) utilize fluorescence flow-cytometry for the leukocyte differential, enabling enhanced subset differentiation based on forward and side scatter as well as RNA content. In addition to providing an accurate and reliable assessment of the complete blood count (CBC), nucleated red blood cells (nRBC) and immature granulocytes (IG), this technology also offers a set of hematological inflammation parameters that quantitatively assess the activation status of neutrophils and lymphocytes . This study analyzes the contribution of these novel parameters to established clinical risk factors in predicting adverse outcomes in a retrospective study of three hundred patients with COVID-19 admitted in this institution. Between May and August 2020 over eleven weeks, a total of 331 consecutive patients required admission for symptomatic COVID-19 in the Sultan Qaboos University hospital in Oman. Testing for SARS CoV-2 was done on standard respiratory specimens for all patients by real-time polymerase chain reaction (RT-PCR). Data for all these patients were retrospectively collected after ethical approval by the institutional review board, and a database, which included relevant demographic, clinical and laboratory data was created. The study was to look for a correlation between the novel neutrophil and lymphocyte activation markers, IG and nRBC offered by the Sysmex TM XN-9100, along with the established clinical risk factors (age, obesity, diabetes and hypertension) with the need for mechanical ventilation and death. All patients who presented to the emergency department of Sultan Qaboos University Hospital (SQUH) with symptoms consistent with COVID-19 and confirmed for the SARS CoV-2 by RTPCR during the period May to August 2020 were included in the study. Patients who had hemoglobinopathies, hematologic or solid malignancy on chemotherapy were excluded. Patients were also excluded if no CBC was done at the time of admission. Specific clinical parameters included co-morbidities, the onset of symptoms, oxygen saturation by pulse oximeter (SpO2) at admission (normal >93%), maximum oxygen requirement (room air, nasal prongs or mask, non-invasive ventilation or mechanical ventilation), time to recovery, death or discharge. In addition the result of a blood culture if done at admission was recorded. The Sysmex TM XN-series auto analyzers also offer accurate quantification of IG and nRBC by fluorescence technology. Absolute values (x 10 9 /l) were used in this study. The IG fraction in the CBC measured by this method comprises promyelocytes, LI-6 concentration was measured on serum samples using the automated ELECSYS IL-6 immunoassay (electrochemiluminescence immunoassay) by the Cobas e-601 immunoassay analyzer (Rosche diagnostics, Switzerland) following the manufacturer's protocol. The used cut-off of IL-6 was 7pg/ml Statistical Analysis Continuous variables were described using medians with the interquartile ranges (IQR) while categorical variables were described using proportions. Pearson's correlation was used for the correlation matrix of the laboratory variables. The impact of laboratory variables on the need for mechanical ventilation and death was assessed using univariable logistic regression. Statistically significant factors were then entered into multivariable logistic regression. The known clinical prognostic factors for the J o u r n a l P r e -p r o o f two outcomes were also entered into the multivariable logistic regression model to assess if factors' impact can predict the outcomes independently. These factors included age, diabetes, obesity and hypertension. Obesity was defined as body mass index of 30 or more. An alpha threshold of 0.05 was used for assessing the statistical significance. Patients with missing weight and height values were labelled obese if treating physicians labelled them as obese before the outcome. The best cut-off value was assessed by maximizing the sensitivity and specificity. The discrimination of the cut-off values was assessed using area under the curve (AUC). The software R program (R version 3.5.1, R Core Team, 2018) was used for all descriptive and analytical statistics. A total of 300 consecutive patients (Table 1 ) who attended the emergency department for COVID-19 were included in this study with a median age of 53 years (IQR:41 -65). The median counts for nRBC, WBC, IG and NEUT-RI were 0.00 x 10 9 /l (IQR: 0.00 -0.00), 6.5 x 10 9 /L (IQR: 4.8 -9.1), 0.02 x 10 9 /l (IQR: 0.00 -0.10) and 48.8 FI (IQR: 46.3 -50.9) respectively. Thirty-nine percent of the included patients had diabetes and 10% had obesity. The median IL-6 value at presentation was 37pg/ml (IQR: 14 -91). Only 7% of patients had bacteremia at presentation or during their admission. The correlation matrix between different laboratory parameters is represented in figure 1 . Overall, the correlation between the parameters was generally in the very weak or weak category except the following: the nRBC with the IG NEUT GI (p=0.28), AS-Lymph (p=0.49) and RE-Lymph (p=0.219) did not predict J o u r n a l P r e -p r o o f death in these patients. In the multivariable analyses with the inclusion of age, obesity, diabetes and hypertension, the statistically significant predictors for death were NEUT-RI (OR = 1.14, p =0.00432), diabetes (OR = 4.11, p = 0.00185) and age (OR = 1.04, p = 0.00896). Obesity (OR = 2.02, p = 0.271), HTN (OR = 0.63, p = 0.347) and WBC (OR = 1.06, p = 0.214) did not reach statistical significance. The optimal cut-off value for the NEUT-RI to predict death was 52 FI with a sensitivity of 44% and a specificity of 86% (AUC = 0.64). In our retrospective single-center study involving three hundred patients admitted with COVID-19, 22% required mechanical ventilation and the overall mortality rate was 12.4%. Multivariable analyses showed NEUT-RI (OR = 1.22, p <0.001), diabetes (OR = 2.56, p = 0.00846) and obesity (OR 6.55, p <0.001) to be significant predictors for the need of mechanical ventilation while NEUT-RI (OR = 1.14, p =0.00432), diabetes (OR = 4.11, p = 0.00185) and age (OR = 1.04, p = 0.00896) predicted death. Although diabetes, obesity and older age had previously been described to be adverse risk factors, this is the first time that activated neutrophils as detected by the Involvement of the pulmonary epithelium by SARS-CoV-2 with influx of neutrophils and inflammation, causes impaired alveolar gas exchange and hypoxia. Although it is well-known for patients with COVID-19 to be hypoxic at presentation, it is likely that there are some who could have subclinical hypoxemia much earlier and that the degree and extent of hypoxic tissue damage and inflammation might be significantly underestimated. Hypoxia and inflammation are intimately linked prompted us to look more closely at this phenomenon in our cohort of 300 patients. We found that IGs correlated with hypoxia at admission but not with IL-6, lending support to massive NETosis and likely tissue hypoxia (rather than the cytokine storm) as causal for intense bone marrow activity to keep up with continued demand for mature neutrophils. shown the presence of activated neutrophils in the peripheral blood of patients with COVID-19 by directly analyzing the neutrophil population using the Sysmex TM XN-9100 automated cell analyser. This novel technology enabled us to rapidly quantify the degree of neutrophil activation and assign a cut-off value of fluorescence intensity, with predictive value for risks of mechanical ventilation and death. In a recent multi-center study done primarily to design and validate a prognostic scoring system using only hemocytometric data by the Sysmex TM technology, activated neutrophils were also found to be significantly associated with critically ill COVID-19 patients (Linssen et al., 2020) . In our study, we analyzed more than one outcome including the need for mechanical ventilation and death. We found activated neutrophils to be an important predictor of these outcomes. Although more studies of neutrophil activation in COVID-19 with this technology are needed to verify these results, the Sysmex TM XN-9100 cell analyzer appears to be a reliable, robust and rapid method to quantify neutrophil activation in the peripheral blood. In summary our study shows the presence of activated neutrophils (NEUT-RI) as measured by the Sysmex TM XN-9100 auto-analyzer in the peripheral blood of patients with COVID-19 at admission, to be an independent predictor for mechanical ventilation and death. From a biological standpoint, these findings imply a central role for neutrophils in the disease's pathophysiology and could potentially lead J o u r n a l P r e -p r o o f to newer therapeutic strategies for COVID-19. Importantly also this noninvasive novel technology, incorporated in a multi-parameter hematology autoanalyzer to detect circulating activated neutrophils, enables rapid turnaround time for clinical and therapeutic decision making. Targeting potential drivers of COVID-19: Neutrophil extracellular traps Leukotriene B4-Neutrophil Elastase Axis Drives Neutrophil Reverse Transendothelial Cell Migration In Vivo The response of macrophages and neutrophils to hypoxia in the context of cancer and other inflammatory diseases Targeting Hypoxia-Induced Inflammation Hypoxia and inflammation Macrophage Clearance of Neutrophil Extracellular Traps Is a Silent Process Pulmonary and cardiac pathology in African American patients with COVID-19: an autopsy series from New Orleans Therapeutic Potential of Resveratrol in COVID-19-Associated Hemostatic Disorders New parameters on the hematology analyser XN-10 (Sysmex TM ) allow to distinguish childhood bacterial and viral infections Endothelial cell dysfunction: a major player in SARS-Cov-2 infection (COVID-19)? Deoxyribonucleases and Their Applications in Biomedicine Integration of inflammatory signals by rolling neutrophils Hypoxia-inducible factors: key regulators of myeloid cells during inflammation antibody synthesizing/secreting cells using the automated routine hematology analyser XE-2100 A novel haemocytometric COVID-19 prognostic score developed and validated in an observational multicentre European hospital-based study Neutrophils in the activation and regulation of innate and adaptive immunity Management of COVID-19 respiratory distress The multifaceted functions of neutrophils A neutrophil activation signature predicts critical illness and mortality in COVID-19 Neutrophil extracellular traps contribute to immunothrombosis in COVID-19 acute respiratory distress syndrome Leukoerythroblastic reaction in a patient with COVID-19 A kinetic model of bone marrow neutrophil production that characterizes late phenotypic maturation Bioinspired DNase-I-Coated Melanin-Like Nanospheres for Modulation of Infection-Associated NETosis Dysregulation Sustained high glucose exposure sensitizes macrophage responses to cytokine stimuli but reduces their phagocytic activity Neutrophil activation and NETosis are the major drivers of thrombosis in heparin induced thrombocytopenia Neutrophil extracellular traps go viral Novel haematological parameters for rapidly monitoring the immune system response. Sysmex White Paper Infection Prolonged exposure to hypoxia induces an autophagy-like cell survival program in human neutrophils Neutrophils and Neutrophil Extracellular Traps Drive Necroinflammation in COVID-19 Innovative Technologies in the evaluation of the Neutrophil Functional Activity in Sepsis SARS-CoV-2-triggered neutrophil extracellular traps mediate COVID-19 pathology 531-Hospitalized Patients with 2019 Novel Coronovirus-Infected Pneumonia in Wuhan, China Excessive Neutrophils and Neutrophil Extracellular Traps in COVID-19 Evaluation of the automated immature granulocyte count(IG) on Sysmex SE-2100 automated hematology analyser vs visual microscopy (NCCLS H20-A) Pathophysiology, Transmission, Diagnosis and Treatment of Coronavirus Disease 2019 (COVID-19) The junctional adhesion molecule JAM-C regulates polarized transendothelial migration of neutrophils in vivo Pathological findings of COVID-19 associated with respiratory distress syndrome three COVID-19 cases by minimally invasive biopsies Temporal changes in immune blood cell parameters in COVID-19 infection and recovery from severe infection Mechanisms of vascular endothelial cell injury in response to intermittent and/or continuous hypoxia exposure and protective effects of anti-inflammatory and anti-oxidant agents granuloytes, WBC: white blood cells, nRBC: nucleated red blood cells, AS-Lymph: antibody-synthesizing lymphocytes, RE-Lymph: reactive lymphocytes, NEUT-GI: neutrophil granularity intensity, NEUT-RI: neutrophil reactivity intensity